Latest Insider Transactions at Greenwich Life Sciences, Inc. (GLSI)
This section provides a real-time view of insider transactions for Greenwich Life Sciences, Inc. (GLSI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Greenwich LifeSciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Greenwich LifeSciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 21
2024
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
1,000
+0.38%
|
$12,000
$12.91 P/Share
|
|
Sep 26
2024
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,500
+0.03%
|
$21,000
$14.63 P/Share
|
|
Aug 12
2024
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
800
+0.3%
|
$10,400
$13.85 P/Share
|
|
Aug 06
2024
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
2,000
+0.04%
|
$26,000
$13.81 P/Share
|
|
Aug 05
2024
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
5,500
+0.1%
|
$71,500
$13.18 P/Share
|
|
Aug 02
2024
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
1,000
+0.38%
|
$15,000
$15.15 P/Share
|
|
Jul 23
2024
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,500
+0.03%
|
$22,500
$15.89 P/Share
|
|
Jul 18
2024
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
1,000
+0.38%
|
$16,000
$16.0 P/Share
|
|
Jun 13
2024
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
174,825
+3.07%
|
$2,447,550
$14.3 P/Share
|
|
Apr 01
2024
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
3,000
+0.06%
|
$57,000
$19.08 P/Share
|
|
Mar 22
2024
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
2,500
+0.05%
|
$47,500
$19.98 P/Share
|
|
Mar 20
2024
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,500
+0.03%
|
$25,500
$17.68 P/Share
|
|
Mar 05
2024
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
30,500
+0.57%
|
$366,000
$12.49 P/Share
|
|
Mar 04
2024
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
4,100
+0.08%
|
$53,300
$13.03 P/Share
|
|
Feb 16
2024
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
10,800
+0.2%
|
$118,800
$11.16 P/Share
|
|
Feb 15
2024
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
12,700
+0.24%
|
$139,700
$11.07 P/Share
|
|
Nov 10
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
5,000
+0.09%
|
$50,000
$10.17 P/Share
|
|
Nov 03
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
3,500
+0.07%
|
$31,500
$9.11 P/Share
|
|
Oct 27
2023
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
500
+0.19%
|
$4,000
$8.57 P/Share
|
|
Oct 26
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
2,500
+0.05%
|
$17,500
$7.97 P/Share
|
|
Oct 25
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
2,500
+0.05%
|
$17,500
$7.91 P/Share
|
|
Oct 10
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.02%
|
$9,000
$9.07 P/Share
|
|
Oct 04
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
2,000
+0.04%
|
$16,000
$8.63 P/Share
|
|
Sep 26
2023
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
600
+0.23%
|
$4,800
$8.71 P/Share
|
|
Sep 19
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
4,000
+0.08%
|
$32,000
$8.95 P/Share
|
|
Sep 11
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.02%
|
$9,000
$9.48 P/Share
|
|
Aug 22
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.02%
|
$9,000
$9.97 P/Share
|
|
Aug 04
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
2,000
+0.04%
|
$20,000
$10.55 P/Share
|
|
Jul 21
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.02%
|
$9,000
$9.2 P/Share
|
|
Jul 13
2023
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
250
+0.1%
|
$2,250
$9.49 P/Share
|
|
May 17
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.02%
|
$11,000
$11.69 P/Share
|
|
Apr 28
2023
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
250
+0.1%
|
$2,750
$11.22 P/Share
|
|
Apr 19
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
7,000
+0.13%
|
$77,000
$11.1 P/Share
|
|
Apr 18
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
2,000
+0.04%
|
$22,000
$11.12 P/Share
|
|
Apr 11
2023
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
1,000
+0.39%
|
$11,000
$11.87 P/Share
|
|
Apr 11
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
5,000
+0.09%
|
$60,000
$12.42 P/Share
|
|
Mar 15
2023
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
250
+0.1%
|
$3,000
$12.71 P/Share
|
|
Mar 10
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.04%
|
$12,000
$12.12 P/Share
|
|
Feb 24
2023
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
250
+0.1%
|
$3,750
$15.39 P/Share
|
|
Feb 17
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
600
+0.02%
|
$9,600
$16.53 P/Share
|
|
Feb 10
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.04%
|
$18,000
$18.68 P/Share
|
|
Feb 03
2023
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
250
+0.1%
|
$5,000
$20.84 P/Share
|
|
Jan 27
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
2,000
+0.07%
|
$38,000
$19.35 P/Share
|
|
Jan 27
2023
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
250
+0.1%
|
$4,750
$19.2 P/Share
|
|
Jan 20
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,500
+0.05%
|
$25,500
$17.37 P/Share
|
|
Jan 13
2023
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
250
+0.1%
|
$4,000
$16.5 P/Share
|
|
Jan 06
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,500
+0.05%
|
$22,500
$15.18 P/Share
|
|
Dec 29
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
4,000
+0.15%
|
$60,000
$15.19 P/Share
|
|
Dec 16
2022
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
250
+0.1%
|
$3,000
$12.94 P/Share
|
|
Dec 16
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.04%
|
$13,000
$13.01 P/Share
|